Voluson Expert 18; Voluson Expert 20; Voluson Expert 22

The GE Healthcare Voluson Expert Series ultrasound systems, classified as Class II medical devices, are designed for advanced diagnostic imaging across various clinical applications, with a specialized focus on OB/GYN and real-time 3D/4D acquisition. These systems integrate cutting-edge AI software features and support diverse probe technologies, validated through comprehensive non-clinical testing to ensure safety and effectiveness.

The GE Healthcare Voluson Expert Series, encompassing models Expert 18, 20, and 22, has received a favorable Class II medical device determination, classifying them as Ultrasonic Pulsed Doppler and Pulsed Echo Imaging Systems with diagnostic transducers. This regulatory clearance signifies their substantial equivalence to existing market devices, enabling their deployment for a broad spectrum of clinical applications. The series is particularly noted for its comprehensive features in general radiology and specialized OB/GYN use, emphasizing real-time 3D/4D acquisition capabilities.These full-featured ultrasound systems support diverse clinical areas including Fetal/OB, Abdominal, Cardiac, Vascular, and Small Organ imaging, utilizing modes such as B, M, PW Doppler, Color Doppler, and Elastography. Key advancements include new probes like RAB7-D and support for wireless Vscan Air SL/CL, alongside enhanced AI software such as SonoLyst for first/second trimester assessments and Sono Pelvic Floor 3.0, and updates to SonoAVC Follicle 2.0. Rigorous non-clinical testing confirmed the systems' safety and efficacy by verifying acoustic output, biocompatibility, and adherence to thermal, electrical, electromagnetic, and mechanical safety standards.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What specific clinical benefits do the new AI features, SonoLyst and Sono Pelvic Floor 3.0, offer over previous versions or traditional methods in terms of diagnostic accuracy or workflow efficiency?; How do the new RAB7-D, Vscan Air SL, and Vscan Air CL probes enhance imaging capabilities or patient comfort for the listed clinical applications compared to prior probe technologies?; What are the long-term clinical outcomes or diagnostic improvements observed in real-world settings with the widespread adoption of the Voluson Expert Series systems, particularly for specialized OB/GYN use?; Are there any limitations or contraindications associated with the use of the Voluson Expert Series, especially concerning specific patient populations or complex diagnostic scenarios?; What is the training requirement or learning curve for clinicians to effectively utilize the advanced AI features and real-time 3D/4D acquisition capabilities of these systems?